Akira Yokomizo

Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria

Hiroshi Katayama, Yukinori Kurokawa, Kenichi Nakamura et al. · Surgery Today · 2015 · 757 citations · Full text

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.

Akira Yokomizo, Mayumi Ono, Hiroki Nanri et al. · PubMed · 1995 · 240 citations

Molecular Pharmacology, Cellular Thiol, Drug Sensitivity +14

Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance

Kohichiroh Yasui, Saori Mihara, Chen Zhao et al. · Cancer Research · 2004 · 217 citations

Genetics, Acquired Drug Resistance, Molecular Genetics +24